Takeda Pharmaceutical (TAK) Income from Non-Controlling Interests (2017 - 2026)
Takeda Pharmaceutical (TAK) reported Income from Non-Controlling Interests of $376,434 for the quarter ended Jun 30, 2026, up 51.3% from $248,800 a year earlier.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's Income from Non-Controlling Interests came in at -$2.27 million; for the year ended Mar 31, 2026, it was $1.75 million, up 24.3% from the prior year.
- Income from Non-Controlling Interests has increased for three consecutive years, with a five-year compound annual growth rate of 2.3% (years ended Mar 2021 to Mar 2026).
- By year, Income from Non-Controlling Interests came in at $1.41 million in the year ended Mar 31, 2025 (+56.6%), $901,435 in the year ended Mar 31, 2024 (+479.9%), $155,447 in the year ended Mar 31, 2023 (-83.7%) and $953,047 in the year ended Mar 31, 2022 (-39.1%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Income from Non-Controlling Interests since the quarter ended Mar 31, 2021.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$637,655 (quarter ended Mar 31, 2026), -$649,790 (quarter ended Dec 31, 2025) and -$1.36 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | 376,434.15 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 376,434.15 |
| Mar 31, 2026 | -637,655.00 |
| Dec 31, 2025 | -649,790.06 |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | 248,799.82 |
| Mar 31, 2025 | -655,461.14 |
| Dec 31, 2024 | -657,777.46 |
| Sep 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | 327,618.88 |
| Mar 31, 2024 | -674,781.42 |
| Sep 30, 2023 | -692,442.51 |
| Jun 30, 2023 | 80,266.13 |
| Dec 31, 2022 | 155,723.01 |
| Sep 30, 2022 | -72,405.39 |
| Jun 30, 2022 | 54,126.69 |
| Jun 30, 2021 | 392,805.78 |
| Mar 31, 2021 | 434,585.04 |
| Dec 31, 2020 | 756,034.62 |
| Jun 30, 2020 | 74,384.13 |
| Sep 30, 2019 | 670,988.96 |
API Access
Takeda Pharmaceutical Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();